Source Date | Board Meeting Date | Details |
05-Feb-2024
|
10-Feb-2024
|
Quarterly Results & Independent Director Meeting
|
06-Nov-2023
|
11-Nov-2023
|
Quarterly Results
|
02-Aug-2023
|
08-Aug-2023
|
A.G.M. & Quarterly Results
|
22-May-2023
|
29-May-2023
|
Dividend & Audited Results
|
03-Feb-2023
|
10-Feb-2023
|
Quarterly Results
|
07-Nov-2022
|
14-Nov-2022
|
Quarterly Results
|
03-Aug-2022
|
09-Aug-2022
|
Quarterly Results
|
23-May-2022
|
28-May-2022
|
Dividend & Audited Results
|
07-Feb-2022
|
11-Feb-2022
|
Quarterly Results
|
24-Nov-2021
|
30-Nov-2021
|
Inter alia, to consider the following: i) Disinvestment of equity shares of Mahi Drugs Private Limited, a wholly-owned subsidiary of the Company and such other connected mailers thereof. ii) Any other items a s may be d ecided by the Board of Directors.
|